Position in LLY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$224,293
+$72,531 QoQ
Shares Held
187
+13.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,897
of 2,003 holders
Holding Since
Jun 2022
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOEY INVESTMENTS, INC holds $4,107,250 across 15 Drug Manufacturers - General names. LLY ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
4,928 | $1,784,527 | |
| 2 | ABBV |
AbbVie Inc.
|
4,275 | $1,075,761 | |
| 3 | JNJ |
Johnson & Johnson
|
2,250 | $571,432 | |
| 4 | GSK |
GSK plc
|
4,897 | $256,700 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
187 | $224,293 | |
| 6 | PFE |
Pfizer Inc
|
5,827 | $140,314 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
300 | $17,286 | |
| 8 | AZN |
Astrazeneca PLC
|
77 | $14,600 |
All Filings in LLY
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $224,293 | 187 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $151,762 | 165 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $112,841 | 105 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $80,115 | 105 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $81,850 | 105 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $86,720 | 105 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $81,060 | 105 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $295,018 | 333 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $301,491 | 333 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $77,796 | 100 | Shares | Sole | 2024-05-10 | |
| 2022-09-30 | $9,700 | 30 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,726 | 30 | Shares | Sole | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||